Pharmafile Logo
Pharmafocus logo
Advanced Search

legal

Showing 15 posts of 15 posts found.

johnson_and_johnson_jj

Missouri Supreme Court ruling could help J&J in talc cases

February 25, 2019
Sales and Marketing Cancer, J&J, JJ, asbestos, baby powder, lawsuits, legal, talc

The Missouri Supreme Court has ruled that the practice of combining two or more cases in order to allow courts …

News
falsified_medicines

Counterfeit drugs – countering the lies

February 4, 2019
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Counterfeit drugs, IP, counterfeit medicines, falsified medicines, intellectual property, law, legal, patent

As the Falsified Medicines Directive comes into effect in February 2019, Louis Goss fact checks ‘common sense’ claims on counterfeit …

Feature
abbvie_0

Chicago Judge overturns $140 million AbbVie AndroGel verdict

August 13, 2018
Sales and Marketing AbbVie, Litigation, androgel, legal, testosterone

A US Judge has overturned a $140.1 million verdict against the New York-listed AbbVie Inc. The verdict, which ruled in …

News
johnson_and_johnson_jj

J&J ordered to pay $4.68 billion to talc-powder plaintiffs

July 13, 2018
Medical Communications J&J, JJ, Johnson and Johnson, legal, talc powder

A Missouri jury has ordered the New Jersey-based healthcare company Johnson and Johnson to pay $4.69 billion to 22 women …

News
shutterstock_92671375

UK High Court rejects ABPI’s challenge to new NICE cost curbs

October 5, 2017
Sales and Marketing ABPI, NHS, NHS England, NICE, legal, pharma, pharmaceutical

The ABPI has been knocked back by the UK High Court in its legal challenge to NICE over new drug …

News
shutterstock_274590824

Ex-Novartis employee found not guilty of deceitful drug advertising

March 17, 2017
Medical Communications, Sales and Marketing Diovan, Novartis, legal

A Tokyo court has ruled finding ex-Novartis employee Nobuo Shirahashi and the company’s Tokyo-based sales arm Novartis Pharma KK not …

News
astrazeneca_crestor_rosuvastatin_40mg

AstraZeneca loses legal bid to block Crestor generics

July 20, 2016
Research and Development, Sales and Marketing AstraZeneca, Crestor, FDA, generics, legal

A US district court judge has refused AstraZeneca’s request for a temporary restraining order blocking the approval of generic versions …

News
pfizer_logo

Pfizer to call off $160 billion merger with Allergan

April 6, 2016
Business Services, Research and Development, Sales and Marketing Allergan, Pfizer, deal, legal, merger and acquisition, regulation

US pharma giant Pfizer Inc (NYSE: PFE) has decided to terminate the $160 billion merger with Botox-maker Allergan Plc (NYSE: …

News

FTC files complaint against Endo for blocking generics of its pain drugs

April 1, 2016
Business Services, Manufacturing and Production, Medical Communications, Sales and Marketing Endo International, FTC, legal, regulation

The US Federal Trade Commission (FTC) has filed a complaint against Endo International (Nasdaq: ENDP) alleging the company used illegal …

News

Whistleblower accuses Novartis of paying bribes in Turkey to push sales

April 1, 2016
Business Services, Medical Communications, Sales and Marketing Financial, Novartis, legal, reuters

An anonymous whistleblower has accused Swiss drugmaker Novartis (SIX: NOVN) of paying bribes in Turkey through a consulting firm to …

News
174571_1

US govt demands records of Novartis’ educational events in kickbacks suit

March 29, 2016
Business Services, Manufacturing and Production, Sales and Marketing Novartis, US government, legal, regulation

Swiss pharma major Novartis (VTX: NOVN) has said the US lawsuit has exploded with the regulators demanding information for about …

News
law

Legal analysis: compliance top of the agenda for big pharma

September 25, 2015
Medical Communications, Sales and Marketing lawyers, legal, pharma industry, reputation

Do you think big pharma suffers from a negative image, and if so, to what extent do you think this …

Feature

Round one to Pfizer in Zoloft lawsuit battle

April 20, 2015
Sales and Marketing Pfizer, Zoloft, antidepressant, birth defects, law suits, legal, sertraline

Pfizer’s Zoloft did not cause a young boy’s birth defects, a jury has ruled, in the first of a thousand …

News
merck image

Merck in $100 million contraceptive settlement

February 10, 2014
Sales and Marketing Merck, birth, birth control, legal, nuvaring

Merck has offered to pay $100 million to resolve thousands of legal claims brought against it for selling a birth …

News
Advair image

GSK ruling: Another failing, but will the industry learn?

July 4, 2012
Medical Communications, Sales and Marketing GSK, fraud, legal, marketing fine

Court papers surrounding GSK’s $3 billion fraud charge make for grim reading, and further damages an industry that already struggles …

News
The Gateway to Local Adoption Series

Latest content

Could targeting the molecular causes of infertility finally transform IVF success rates?

January 29, 2026

Digital mental health technologies – a valuable tool in supporting people with depression and anxiety

January 29, 2026

Barts Health NHS Trust collaborates with H.I.G. Realty on healthcare innovation building

January 29, 2026

Rentschler Biopharma appoints Detra Glinatsis as Head of Business Development US

January 29, 2026

Five Facts about spinal muscular atrophy

January 28, 2026